Home > Boards > US Listed > Medical - Drugs >

Moleculin Biotech (MBRX)

MBRX RSS Feed
Add MBRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/16/2021 5:29:24 PM - Followers: 90 - Board type: Free - Posts Today: 0

wally

WALTER V. KLEMP
President, CEO and Chairman

Company web. site  http://www.moleculin.com
   
Authorized Shares      100,000,000 as of  05/01.2020
Outstanding Shares     60,403,164  as of  05/01/2020

Quarterly Report (10-q)    May 11, 2020
https://ih.advfn.com/stock-market/NASDAQ/moleculin-biotech-MBRX/stock-news/82428874/quarterly-report-10-q

Second Quarter Earnings 2019
 https://ih.advfn.com/stock-market/NASDAQ/moleculin-biotech-MBRX/stock-news/80558492/moleculin-biotech-inc-reports-financial-results

Moleculin Presentation May 31,2019
https://ir.moleculin.com/all-sec-filings

Moleculin Announces First Patients Treated in European Annamycin Clinical Trial
https://finance.yahoo.com/news/moleculin-announces-first-patients-treated-113000512.html

Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
 https://www.otcmarkets.com/stock/MBRX/news/story?e&id=1276755

Moleculin Announces Significant Milestone Achieved in Glioblastoma Trial
https://ih.advfn.com/p.php?pid=nmona&article=78590137&symbol=MBRX


Moleculin Announces Positive Data on WP1066 in Pre-Clinical Trials
https://ih.advfn.com/p.php?pid=nmona&article=78537668&symbol=MBRX


Moleculin Announces New Data Discovery Confirming Significant Increase in Potential to Starve Cancerous Tumors
https://ih.advfn.com/p.php?pid=nmona&article=78433601&symbol=MBRX

Moleculin receives approval for leukemia clinical trial; shares ahead 23% premarket
https://seekingalpha.com/news/3365150-moleculin-receives-approval-leukemia-clinical-trial-shares-ahead-23-percent-premarket


Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors
https://ir.moleculin.com/press-releases/detail/89/moleculin-targets-accelerated-fda-approval-of-wp1732
 Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial
https://globenewswire.com/news-release/2018/05/03/1495957/0/en/Moleculin-Announces-Engagement-with-Voisin-Consulting-Life-Sciences-to-Expand-Annamycin-Clinical-Trial.html

Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
https://finance.yahoo.com/news/moleculin-enters-agreement-seidman-cancer-123000495.html

Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
http://www.marketwired.com/press-release/moleculin-announces-grant-funded-collaboration-expand-understanding-new-discovery-2246407.htm

Exclusive: Moleculin CEO Says Acute Myeloid Leukemia Candidate Could Be 'Remarkable' https://www.benzinga.com/general/biotech/18/03/11260689/exclusive-moleculin-ceo-says-acute-myeloid-leukemia-candidate-could-b

 

Moleculin Biotech (MBRX) Buys Active Drug Compound for Treatment of Brain Cancer https://www.streetinsider.com/Corporate+News/Moleculin+Biotech+%28MBRX%29+Buys+Active+Drug+Compound+for+Treatment+of+Brain+Cancer/13211319.html




Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO

Metabasis Therapeutics (NASDAQ:MBRX)
Historical Stock Chart

Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).

In honor of the occasion, Walter Klemp, Chief Executive Officer, will ring the Closing Bell.

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Thursday, June 2, 2016 – 3:45 p.m. to 4:00 p.m. ET

Moleculin Biotech Media Contact:
Sean Leous
(646) 863-8998
sleous@pcgadvisory.com
MBRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MBRX News: Current Report Filing (8-k) 02/19/2021 05:02:24 PM
MBRX News: Underwriters exercise over-allotment option in Moleculin offering 02/10/2021 04:45:10 PM
MBRX News: Current Report Filing (8-k) 02/10/2021 04:17:09 PM
MBRX News: Moleculin Announces Full Exercise of Over-Allotment Option 02/10/2021 04:15:00 PM
MBRX News: Amended Statement of Ownership (sc 13g/a) 02/10/2021 11:34:54 AM
PostSubject
#3476   I’m holding my shares in hopes but without amber818 02/16/21 05:29:24 PM
#3474   I hear you Sphinx. I am invested Andy T 02/16/21 02:17:33 PM
#3473   I can’t believe that this message board has TheSprinx 02/15/21 09:22:23 PM
#3472   "Annamycin is a “next-generation” anthracycline that has recently Chemist823 02/14/21 11:28:26 AM
#3471   This looks to me to be severely under priced. Chemist823 02/11/21 03:44:07 PM
#3470   5.70!!!!! TheSprinx 02/10/21 07:18:29 AM
#3469   Make it 5.18!!! Lol TheSprinx 02/09/21 05:45:02 PM
#3468   Check that $5.15!! TheSprinx 02/09/21 04:53:37 PM
#3467   $5.10!! News Eminent TheSprinx 02/09/21 03:28:43 PM
#3466   It was there confirmation that they closed. Share TheSprinx 02/09/21 02:32:19 PM
#3465   Prolly another R/S tigertiger88 02/08/21 04:39:44 PM
#3464   I smell something great about to Happen! TheSprinx 02/08/21 03:34:30 PM
#3463   Sold my shares and deleted from my watchlist Wolf91 02/04/21 09:36:51 AM
#3462   Offering at $4.75. Closes Friday. Time to load TheSprinx 02/03/21 02:24:24 PM
#3461   rinse, repeat tigertiger88 02/03/21 10:42:25 AM
#3460   Not looking good today. Dennisb68 02/03/21 09:17:51 AM
#3459   Selling off in AH trading. Down 1/2 of Dennisb68 02/02/21 07:05:56 PM
#3458   * * $MBRX Video Chart 02-02-2021 * * ClayTrader 02/02/21 05:59:27 PM
#3457   I sold out right after Waiting for this to TheSprinx 02/02/21 04:41:17 PM
#3456   Moleculin Announces Proposed Underwritten Public Offering Download as tigertiger88 02/02/21 04:25:17 PM
#3455   Supplement No. 1 dated February 2, 2021 to tigertiger88 02/02/21 04:09:13 PM
#3454   $10 SOON 2020trader 02/02/21 01:06:55 PM
#3453   If we do not bounce soon ,we will Liagury 02/02/21 12:15:45 PM
#3452   4x times the O/S people selling for a loss and peterus 02/02/21 11:28:25 AM
#3451   They had to get institutional investors to invest TheSprinx 02/02/21 11:23:14 AM
#3450   I can't see how it doesn't bounce soon Wolf91 02/02/21 11:15:24 AM
#3449   6.60s bounce ? peterus 02/02/21 11:00:23 AM
#3448   greedy shorts hope you get burned big time peterus 02/02/21 10:56:17 AM
#3447   $7 bounce coming peterus 02/02/21 10:28:35 AM
#3446   Yea from an early PR they state O/S Wolf91 02/02/21 10:19:12 AM
#3445   i see O/S 10.410.719 mil could break $10 today peterus 02/02/21 10:01:52 AM
#3444   whats the O/S here ? peterus 02/02/21 09:59:54 AM
#3443   Or more cushion to stay high above the Wolf91 02/02/21 09:58:02 AM
#3442   Maybe to appear more attractive to institutions with Wolf91 02/02/21 09:56:47 AM
#3441   I just wonder why RS yesterday while they tilator 02/02/21 09:51:56 AM
#3440   I'm a veterinarian, I know this is an Wolf91 02/02/21 09:47:28 AM
#3439   BAM!!! TheSprinx 02/02/21 09:44:21 AM
#3438   $MBRX stock is screaming for the top after AlphaStockNews 02/02/21 09:12:53 AM
#3437   should be a good day if they do tigertiger88 02/02/21 08:29:16 AM
#3436   Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung tigertiger88 02/02/21 07:36:29 AM
#3435   Dump a thon imo tigertiger88 02/01/21 09:06:04 AM
#3434   https://www.stocktitan.net/news/MBRX/moleculin-signs-agreement-with-catalyst-cli TheSprinx 02/01/21 08:36:58 AM
#3433   Yup but not all R/S are bad. Just TheSprinx 01/29/21 10:30:57 PM
#3432   Now you see why nobody here. king oil 01/29/21 06:30:18 PM
#3431   Yeah. It will hit 5 after the 1:6 king oil 01/29/21 06:29:31 PM
#3430   The kiss of death for this stock. Dennisb68 01/29/21 11:32:19 AM
#3429   Moleculin Announces Reverse Stock Split Source: PR Newswire (US) HOUSTON, tigertiger88 01/29/21 09:25:27 AM
#3428   Reverse Stock Split 1:6 tigertiger88 01/29/21 09:18:57 AM
#3427   Roth Capital analyst Jonathan Aschoff maintained a Buy coffee2go 01/24/21 09:06:50 AM
#3426   https://www.smarteranalyst.com/new-blurbs/roth-capital-sticks-to-their-buy-ratin coffee2go 01/24/21 09:06:27 AM
PostSubject
Consent Preferences